[1] Headache Classi f icat ion Commit tee of the Internat ional Headache Society（IHS）. The international classification of headache disorders，3rd edition[J]. Cephalalgia，2018，38（1）：1-211.
[2] ZHU K，BORN D W，DILLI E. Secondary headache：current update[J]. Headache，2020，60（10）：2654-2664.
[3] PETRIDIS A K，KAMP M A，CORNELIUS J F，et al. Aneurysmal subarachnoid hemorrhage[J]. Dtsch Arztebl Int，2017，114（13）：226-236.
[4] CALABRESE L H，DODICK D W，SCHWEDT T J，et al. Narrative review：reversible cerebral vasoconstriction syndromes[J]. Ann Intern Med，2007，146（1）：34-44.
[5] ENGELTER S T，TRAENKA C，LYRER P. Dissection of cervical and cerebral arteries[J/OL].Curr Neurol Neurosci Rep，2017，17（8）：59[2021-12-04]. https://doi.org/10.1007/s11910-017-0769-3.
[6] DIAMANTI S，LONGONI M，AGOSTONI E C. Leading symptoms in cerebrovascular diseases：what about headache?[J/OL]. Neurol Sci，2019，40（Suppl1）：147-152[2021-12-04]. https://doi.org/10.1007/s10072-019-03793-8.
[7] ISLER H. The Galenic tradition and migraine[J]. J Hist Neurosci，1992，1（3）：227-233.
[8] TFELT-HANSEN P C，KOEHLER P J. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward[J]. Cephalalgia，2008，28（8）：877-886.
[9] LEÃO A A P. Spreading depression of activity in the cerebral cortex[J]. J Neurophysiol，1944，7（6）：359-390.
[10] AYATA C. Spreading depression and neurovascular coupling[J/OL]. Stroke，2013，44（6 Suppl 1）：S87-S89[2021-12-04]. https://doi.org/10.1161/STROKEAHA.112.680264.
[11] AYATA C，LAURITZEN M. Spreading depression，spreading depola r izat ions，and the cerebral vasculature[J]. Physiol Rev，2015，95（3）：953-993.
[12] PRESA J L，SARAVIA F，BAGI Z，et al. Vasculoneuronal coupling and neurovascular coupling at the neurovascular unit：impact of hypertension[J/OL]. Front Physiol，2020，11：584135[2021-12-04]. https://doi.org/10.3389/fphys.2020.584135.
[13] LAI J，DILLI E. Migraine aura：updates in pathophysiology and management[J/OL]. Curr Neurol Neurosci Rep，2020，20（6）：17[2021-12-04]. https://doi.org/10.1007/s11910-020-01037-3.
[14] LAURITZEN M，DREIER J P，FABRICIUS M，et al. Clinical relevance of cortical spreading depression in neurological disorders：migraine，malignant stroke，subarachnoid and intracranial hemorrhage，and traumatic brain injury[J]. J Cereb Blood Flow Metab，2011，31（1）：17-35.
[15] RADDANT A C，RUSSO A F. Calcitonin generelated peptide in migraine：intersect ion of peripheral inflammation and central modulation[J/OL]. Expert Rev Mol Med，2011，13：e36[2021-12-04]. https://doi.org/10.1017/S1462399411002067.
[16] BURNSTOCK G. Purinergic signalling and endothelium[J]. Curr Vasc Pharmacol，2016，14（2）：130-145.
[17] RODRÍGUEZ-OSORIO X，SOBRINO T，BREA D，et al. Endothelial progenitor cells：a new key for endothelial dysfunction in migraine[J]. Neurology，2012，79（5）：474-479.
[18] LIMAN T G，BACHELIER-WALENTA K，NEEB L，et al. Circulating endothelial microparticles in female migraineurs with aura[J]. Cephalalgia，2015，35（2）：88-94.
[19] TIETJEN G E，HERIAL N A，WHITE L，et al. Migraine and biomarkers of endothelial activation in young women[J]. Stroke，2009，40（9）：2977-2982.
[20] JOSEPH E K，GREEN P G，BOGEN O，et al. Vascular endothelial cells mediate mechanical stimulation-induced enhancement of endothelin hyperalgesia via activation of P2X2/3 receptors on nociceptors[J]. J Neurosci，2013，33（7）：2849-2859.
[21] BEN AISSA M，TIPTON A F，BERTELS Z，et al. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain[J]. Cephalalgia，2018，38（8）：1471-1484.
[22] WEI X，MELEMEDJIAN O K，AHN D D，et al. Dural fibroblasts play a potential role in headache pathophysiology[J]. Pain，2014，155（7）：1238-1244.
[23] PEROUTKA S J. Migraine：a chronic sympathetic nervous system disorder[J]. Headache，2004，44（1）：53-64.
[24] SUZUKI N，HARDEBO J E，KÅHRSTRÖM J，et al. Selective electrical stimulation of postganglionic cerebrovascular parasympathetic nerve fibers originating from the sphenopalatine ganglion enhances cortical blood flow in the rat[J]. J Cereb Blood Flow Metab，1990，10（3）：383-391.
[25] HAUG S R，HEYERAAS K J. Effects of sympathectomy on experimentally induced pulpal inflammation and periapical lesions in rats[J]. Neuroscience，2003，120（3）：827-836.
[26] JÄNIG W，LEVINE J D，MICHAELIS M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma[J/OL]. Prog Brain Res，1996，113：161-184[2021-12-04]. https://doi.org/10.1016/s0079-6123（08）61087-0.
[27] SHINDER V，GOVRIN-LIPPMANN R，COHEN S，et al. Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury[J]. J Neurocytol，1999，28（9）：743-761.
[28] PLUTEANU F，RISTOIU V，FLONTA M L，et al. Alpha（1）-adrenoceptor-mediated depolarization and beta-mediated hyperpolarization in cultured rat dorsal root ganglion neurones[J]. Neurosci Lett，2002，329（3）：277-280.
[29] FINSTERER J，ZARROUK-MAHJOUB S. Headache in mitochondrial disorders[J/OL]. Clin Neurol Neurosurg，2018，166：44-49[2021-12-04]. https://doi.org/10.1016/j.clineuro.2018.01.020.
[30] MONTAGNA P，SACQUEGNA T，MARTINELLI P，et al. Mitochondrial abnormalities in migraine. Preliminary findings[J]. Headache，1988，28（7）：477-480.
[31] YOUNIS S，HOUGAARD A，VESTERGAARD M B，et al. Migraine and magnetic resonance spectroscopy：a systematic review[J]. Curr Opin Neurol，2017，30（3）：246-262.
[32] American Association of Neurological Surgeons （AANS），American Society of Neuroradiology （ASNR），Cardiovascular and Interventional Radiology Society of Europe（CIRSE），et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke[J]. Int J Stroke，2018，13（6）：612-632.
[33] SHOEIBI A，OLFATI N，SOLTNI SABI M，et al. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache：an open-label，addon，controlled trial[J]. Acta Neurol Belg，2017，117（1）：103-109.
[34] DAVIDSON S M，ADAMEOVÁ A，BARILE L，et al. Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury[J]. J Cell Mol Med，2020，24（7）：3795-3806.
[35] SULLIVAN P G，R ABCHEVSKY A G，WALDMEIER P C，et al. Mitochondrial permeability transition in CNS trauma：cause or effect of neuronal cell death?[J]. J Neurosci Res，2005，79（1/2）：231-239.
[36] MAJAMAA K，RUSANEN H，REMES A M，et al. Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome[J]. Life Sci，1996，58（8）：691-699.
[37] ANTTILA V，WINSVOLD B S，GORMLEY P，et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine[J]. Nat Genet，2013，45（8）：912-917.
[38] GORMLEY P，ANTTILA V，WINSVOLD B S，et al. Correction：corrigendum：meta-analysis of 375000 individuals identifies 38 susceptibility loci for migraine[J]. Nat Genet，2016，48（10）：1296.
[39] DEBETTE S，KAMATANI Y，METSO T M，et al. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection[J]. Nat Genet，2015，47（1）：78-83.
